Literature DB >> 7601702

Paralytic illness resembling inflammatory polyradiculoneuropathy in a chimpanzee.

P L Alford1, W C Satterfield.   

Abstract

An adult male chimpanzee housed in an outdoor corral with a group of other chimpanzees had an acute onset of ascending motor paresis that progressed to flaccid tetraplegia over 3 days. Tendon reflexes were weak, and CSF protein concentration was high. The chimpanzee regained normal mobility over several months. This chimpanzee's ascending, symmetrical, monophasic, flaccid paralytic illness, with albuminocytologic dissociation in CSF, and recovery following supportive treatment, was characteristic of inflammatory polyradiculoneuropathy, known as Guillain-Barré syndrome in human beings. Coonhound paralysis and experimentally induced allergic neuritis are the counterparts in dogs and laboratory animals, respectively, of the syndrome. In human beings, the syndrome is apparently immunologically mediated, as it is known to develop after bacterial and viral infections, vaccinations, and surgery or injury. The chimpanzee of this report had been given a rabies vaccination and had been treated for dental abscess 12 days prior to onset of signs, and had been inoculated with material containing neuronal antigens 20 years prior to onset of signs.

Entities:  

Mesh:

Year:  1995        PMID: 7601702

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  2 in total

Review 1.  Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review.

Authors:  Shyamesh Kumar; Hannah Laurence; Michael A Owston; R Mark Sharp; Priscilla Williams; Robert E Lanford; Gene B Hubbard; Edward J Dick
Journal:  J Med Primatol       Date:  2017-05-23       Impact factor: 0.667

2.  Behavioral recovery from tetraparesis in a captive chimpanzee.

Authors:  Misato Hayashi; Yoko Sakuraba; Shohei Watanabe; Akihisa Kaneko; Tetsuro Matsuzawa
Journal:  Primates       Date:  2013-05-15       Impact factor: 2.163

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.